DNA methylation of multiple tumor-related genes in association with overexpression of DNA methyltransferase 1 (DNMT1) during multistage carcinogenesis of the pancreas

Carcinogenesis
Dun-Fa PengSetsuo Hirohashi

Abstract

To evaluate the significance of alterations in DNA methylation during multistage carcinogenesis of the pancreas, tissue samples of 13 peripheral pancreatic duct epithelia showing no remarkable histological changes without inflammatory background (DE), 20 peripheral pancreatic duct epithelia showing no remarkable histological changes with inflammatory background (DEI), 40 pancreatic intraepithelial neoplasias (PanIN) and 147 areas of ductal carcinoma were microdissected from surgically resected specimens from 58 patients and were embedded into agarose beads. The embedded tissue samples were subjected to methylation-specific PCR (MSP) to evaluate the DNA methylation status of the p14, p15, p16, p73, APC, hMLH1, MGMT, BRCA1, GSTP1, TIMP-3, CDH1 and DAPK-1 genes. The prevalence of DNA methylation of at least one of the 12 genes and the average number of methylated genes were significantly higher in both DEI (60% and 0.85 +/- 0.88, P = 0.0151 and P = 0.0224, respectively) and PanIN (67.5% and 0.95 +/- 0.85, P = 0.0014 and P = 0.0028, respectively) than in DE (15.4% and 0.15 +/- 0.38), and were further increased in ductal carcinoma (98.3% and 2.50 +/- 1.35, P < 0.0001 and P < 0.0001, respectively). The BRCA1, APC, p16 and TIMP-3 gene...Continue Reading

References

Sep 17, 1996·Proceedings of the National Academy of Sciences of the United States of America·P J LeeA P Feinberg
Jul 21, 1999·Proceedings of the National Academy of Sciences of the United States of America·M ToyotaJ P Issa
Mar 4, 2000·Laboratory Investigation; a Journal of Technical Methods and Pathology·S KitazawaS Maeda
May 9, 2001·The American Journal of Surgical Pathology·R H HrubanG J Offerhaus
Apr 5, 2002·Nature·Ina RheeBert Vogelstein
Aug 3, 2002·Oncogene·Peter A Jones
Nov 13, 2002·Gut·D MalkaP Ruszniewski
Feb 6, 2003·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael J Thun
Mar 14, 2003·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·R M Bright-Thomas, R Hargest
Nov 25, 2003·The New England Journal of Medicine·James G Herman, Stephen B Baylin
May 29, 2004·Annals of Surgery·Buckminster FarrowB Mark Evers
Jun 3, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Carmela BegerHans G Beger
Dec 8, 2004·Surgery Today·Tamotsu KurokiTakashi Kanematsu
Mar 10, 2005·The Journal of Biological Chemistry·Agoston T AgostonWilliam G Nelson
May 18, 2005·The American Journal of Surgical Pathology·N Volkan AdsayJeanette D Cheng

❮ Previous
Next ❯

Citations

Feb 13, 2008·Langenbeck's Archives of Surgery·Lucia C FryPeter Malfertheiner
Sep 3, 2008·Human Genetics·Wigdan Al-SukhniSteven Gallinger
Feb 4, 2012·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Jing-Jing ZhangYi Miao
Dec 25, 2007·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Norihiro SatoMichael Goggins
Jun 14, 2013·Nature Reviews. Cancer·Winston Timp, Andrew P Feinberg
Mar 3, 2011·Carcinogenesis·Shirley OghamianPeter W Laird
Apr 29, 2009·World Journal of Gastroenterology : WJG·Hong FanYun-Feng Shan
Dec 7, 2013·Apoptosis : an International Journal on Programmed Cell Death·Yide HuangYao Lin
Jan 7, 2014·Acta Biochimica Et Biophysica Sinica·Anthony ScottZhenghe Wang
Feb 13, 2009·Expert Review of Gastroenterology & Hepatology·Christian GemmelJürgen F Riemann
May 23, 2012·Urologic Oncology·Deepika DhawanDeborah W Knapp
Sep 10, 2008·Mutation Research·Suhasni GopalakrishnanKeith D Robertson
Apr 12, 2008·International Journal of Cancer. Journal International Du Cancer·Xiaoyun LiaoAnnie Nga-Yin Cheung
Nov 7, 2006·Cancer Science·Kimishige AkinoTakashi Tokino
Jan 31, 2012·International Journal of Cancer. Journal International Du Cancer·Akiko HoriuchiIkuo Konishi
Sep 25, 2012·Molecular Carcinogenesis·Harumi HataToshio Nakadate
May 13, 2008·Cancer Letters·Jens M TeodoridisRobert Brown
Oct 18, 2011·Journal of Experimental & Clinical Cancer Research : CR·Yi ZhangRui Chen
May 14, 2014·Frontiers in Oncology·Dharmalingam SubramaniamShrikant Anant
Jun 20, 2016·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·T Iglesias GonzálezM Montes-Bayón

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

Cadherins and Catenins

Cadherins (named for "calcium-dependent adhesion") are a type of cell adhesion molecule (CAM) that is important in the formation of adherens junctions to bind cells with each other. Catenins are a family of proteins found in complexes with cadherin cell adhesion molecules of animal cells: alpha-catenin can bind to β-catenin and can also bind actin. β-catenin binds the cytoplasmic domain of some cadherins. Discover the latest research on cadherins and catenins here.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Carcinoma, Ductal

Ductal carcinoma is a malignant neoplasm involving the ductal systems of any of a number of organs, such as the mammary glands, pancreas, prostate or lacrimal gland. Discover the latest research on ductal carcinoma here.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.